Show simple item record

dc.creatorMirza, Alicia A.
dc.creatorRad, Elika J.
dc.creatorMohabir, Paul K.
dc.date.accessioned2020-09-22T16:18:28Z
dc.date.available2020-09-22T16:18:28Z
dc.date.created2020
dc.identifier.issn2213-0071spa
dc.identifier.otherhttps://doi.org/10.1016/j.rmcr.2020.101226spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/13574
dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine.spa
dc.format.extent8 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherRespiratory Medicine Case Reportsspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCystic fibrosisspa
dc.subjectPulmonaryspa
dc.subjectCovid-19spa
dc.subjectInfection controlspa
dc.titleCystic fibrosis and COVID-19: Care considerationsspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.rmcr.2020.101226spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record